New York, NY, May 4, 2005 – The Lupus Research Institute (LRI), the national nonprofit organization solely dedicated to novel research to prevent, treat and cure lupus, has appointed Brian L. Kotzin, M.D., vice-president of global clinical development at Amgen, Inc. and Robert S. Schwartz, M.D., deputy editor of the New England Journal of Medicine, to its Scientific Advisory Board.
"We welcome the addition of Dr. Kotzin and Dr. Schwartz—two of the country's preeminent scientists in rheumatology, immunology and hematology—to the leadership of the Lupus Research Institute," said LRI Scientific Advisory Board Chairman William Paul, MD. "Both have made significant contributions to the scientific understanding of lupus. Their years of clinical experience and research excellence will provide valuable insight and guidance for the groundbreaking work of the LRI."
Before joining the Inflammation Therapeutic Area at Amgen, Inc., the world's largest biotechnology company, Dr. Kotzin was the head of the division of clinical immunology at the University of Colorado Health Sciences Center in Denver, CO, and the director of the Denver Autoimmunity Center of Excellence.
Dr. Kotzin received his medical degree from Stanford University School of Medicine and completed his fellowship in rheumatology and medicine at Beth Israel Hospital in Boston, MA. He was a postdoctoral fellow in the division of immunology and rheumatology at Stanford University School of Medicine. He has received numerous honors, including the Henry Claman Chair in Clinical Immunology, the Chairmanship of the National Institutes of Health Autoimmunity Centers of Excellence, the Kirkland Scholar Award for Lupus Research, and the Gretchen Kramer Award for Outstanding Contributions to Medicine.
Dr. Kotzin is an appointed member of the Advisory Council of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) at NIH. Listed as one of "America's Best Doctors" by U.S. News and World Report, he is an associate editor for Autoimmunity, a consulting editor for the Journal of Clinical Investigation, and serves on the editorial board of Autoimmunity Reviews. He has published over 200 papers and book chapters.
Dr. Robert Schwartz is a deputy editor for the New England Journal of Medicine where he also serves as the book review editor. He is a lecturer in medicine at Harvard University Medical School, a professor of medicine at Tufts University School of Medicine, and serves as Distinguished Physician at the New England Medical Center.
Dr. Schwartz earned his medical degree from New York University School of Medicine, and completed his residency at Montefiore Hospital and Yale New Haven Hospital. He was a clinical fellow and research fellow in hematology at the New England Medical Center Hospital. Among his many honors, Dr. Schwartz has been the recipient the Distinguished Faculty Award, Tufts University School of Medicine (1992), the Sandoz Prize for Immunology (1995), the Medawar Prize (2000), and the Thomas Starzl Prize (2003). He is also a fellow of the American Association for the Advancement of Science and the American College of Physicians. He now serves on the editorial board of Current Opinion in Immunology and has been published in over 300 medical journals and publications.